The entire board of DNA testing company 23andMe resigned after a conflict with CEO Anne Wojcicki over her plan to take the ...

This proposal came as 23andMe's valuation plummeted from $6 billion in 2021 to under $150 million. The company has faced ...

Overview of the Recent Transaction On September 30, 2024, SC US (TTGP), LTD., a prominent investment firm, initiated a new ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...